The global STD diagnostics market is anticipated to witness a higher CAGR in the forecast period. Sexually transmitted infections caused by HIV type 1 and type 2 pose as important study areas with reference to public health. Rise in mortality rate, cervical cancer, ectopic pregnancy and infertility as well as HIV-related illness, all leads to empirical study of HIV and STD simultaneously. Under a syndromatic approach, STD’s rely on using flowcharts for individual STI syndrome. The flowcharts allow diagnoses of common STD syndromes and availability of drugs and medication provision in a specific country.
The market for STD diagnostics is highly driven by rise in R&D activities and a significant shift observed in laboratory testing to point of care testing. Increasing cases of having multiple sex partners and practicing unsafe sex is likely to contribute in augmenting the market size in the near future. In addition, rise in drug addiction is indirectly proportional to the market growth.
STD diagnostics industry is segmented by type into chlamydia testing, gonorrhoea testing, syphilis testing, herpes simplex virus testing, virus testing, chancroid testing and human immunodeficiency virus testing. Location of testing segment for STD diagnostics market includes point of care testing, laboratory testing. Segmentation by testing devices for STD diagnostics industry include point of care devices and laboratory devices.
Geographical segmentation for STD diagnostics market include North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America STD diagnostics industry is anticipated to rise at a significant CAGR in the forthcoming period due to prevalence of health insurance plans and availability of FDA approved testing devices bolsters the market growth in the near future. Europe market is anticipated to grow at a significant CAGR in the forecast period.
Asia-Pacific region accounts for a higher share in the regional market accounting for a strong market position in the global scenario. APAC regions possess a high number of sexually transmitted diseases with an immediate need for medical attention and positive initiatives by NGO to create hygiene awareness among sex workers.
The key players in the STD diagnostics market include HologicInc, Danaher Corporation, and bioMerieux, Cepheid Inc, AlereInc, HologicInc, Abbott Laboratories, Roche Holdings AG, Affymetrix, Becton Dickinson, Orasure and DiaSorin. The key players emphasize effective collaboration and strategic alliances pertaining to technology.
Global STD Diagnostics Type Outlook (Revenue, USD Billion, 2012 - 2022)
• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
Global STD Diagnostics Location of Testing Outlook (Revenue, USD Billion, 2012 - 2022)
• Laboratory Testing
• Commercial/Private Labs
• Public Health Labs
• Point of Care (PoC) testing
Global STD Diagnostics Testing Device Outlook (Revenue, USD Billion, 2012 - 2022)
• Laboratory Devices
• Thermal Cyclers - PCR
• Lateral Flow Readers – Immuno chromatographic assays
• Flow Cytometers
• Differential Light Scattering machines
• Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
• Point of Care (PoC) Devices
• Phone chips (micro fluidics + ICT)
• Portable/bench top/rapid diagnostic kits
STD Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2022)
• North America
• Asia Pacific
• Latin America
• South Africa
Research Support Specialist, USA
FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...